CV Lattes
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Botucatu. Faculdade de Medicina (FMB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Human Medicine at Universidade Estadual Paulista Júlio de Mesquita Filho (1999), master's degree (2005) and doctorate (2009) in P.G. in Gynecology, Obstetrics and Mastology from Universidade Estadual Paulista Júlio de Mesquita Filho. Physician, Department of Gynecology and Obstetrics, Universidade Estadual Paulista Júlio de Mesquita Filho. Responsible for the Diagnostic Imaging Sector, the Oncoplasty Sector and the Breast Reconstruction Sector of the Mastology Evaluation Center Prof. Emeritus Laurival A. De Luca CAM-HCFMB. Member of the FEBRASGO National Specialized Commission on Mammary Imaging. Member of the Brazilian Society of Regional Mastology São Paulo. Deputy Treasurer of the Brazilian Society of Regional Mastology São Paulo in the three-year period from January 1, 2017 to January 1, 2020. Currently Vice President of the Brazilian Society of Regional Mastology São Paulo, for the next three-year period from January 1, 2020 to December 31 December 2022. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Breast cancer is the most incident, prevalent, and lethal type of cancer among women in Brazil and worldwide. According to the International Agency for Research on Cancer (IARC)¹, approximately 2.3 million new cases were estimated in 2020. Furthermore, according to the Brazilian National Cancer Institute (INCA)², between 2020 and 2022, an average of 66,280 new cases per year was expected …
Introduction: Breast cancer is the leading cause of cancer-related death among women in Brazil and the 15th leading cause of mortality worldwide. Screening programs are essential to reduce mortality, with mammography being the gold standard. For high-risk women, magnetic resonance imaging (MRI) is preferred due to its higher sensitivity. Background parenchymal enhancement (BPE) on MRI, de…
Breast cancer represents the most prevalent neoplasm among women globally, affecting individuals in both developing and developed countries. According to the International Agency for Research on Cancer (IARC) in 2020, more than 2.3 million cases of breast cancer were diagnosed, surpassing lung cancer cases and currently being the most prevalent type of cancer, accounting for 11.7% of the …
Breast cancer is a complex and heterogeneous disease, with specific subtypes of tumors associated with different prognosis. Currently, the genomic classification of the different molecular types of breast tumors is a key point in the clinical management of patients, allowing thepersonalization of treatment and avoiding unnecessary actions and side effects efeitos. However, genomic analysi…
Breast cancer is a major public health problem, being the world's leading cause of cancer deathin women and the most prevalent (excluding cases of non-melanoma skin cancer). There arefew studies that analyze prognostic factors, prevalence and survival rate, which are related tothe different subtypes of breast cancer in Brazilian patients. This study aims, therefore, todescribe these varia…
(Only some records are available in English at this moment)
| 2 | Upcoming scholarships in Brazil |
| 4 | Completed scholarships in Brazil |
| 6 | All Scholarships |
| Associated processes | |